European Radiology Experimental | |
In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging | |
Original Article | |
Corby Fink1  Gregory A. Dekaban1  Julia J. Gevaert2  Paula J. Foster2  Jimmy D. Dikeakos3  John W. Barrett4  | |
[1] Biotherapeutics Research Laboratory, Robarts Research Institute, London, ON, Canada;Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada;Cellular and Molecular Imaging Group, Robarts Research Institute, London, ON, Canada;Department of Medical Biophysics, University of Western Ontario, London, ON, Canada;Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada;Department of Otolaryngology–Head and Neck Surgery, University of Western Ontario, London, ON, Canada; | |
关键词: Adenoviridae; Cell tracking; Immunotherapy; Magnetic iron oxide nanoparticles; Mice (inbred C57BL/6); | |
DOI : 10.1186/s41747-023-00359-4 | |
received in 2023-03-07, accepted in 2023-05-30, 发布年份 2023 | |
来源: Springer | |
【 摘 要 】
BackgroundDespite widespread study of dendritic cell (DC)-based cancer immunotherapies, the in vivo postinjection fate of DC remains largely unknown. Due in part to a lack of quantifiable imaging modalities, this is troubling as the amount of DC migration to secondary lymphoid organs correlates with therapeutic efficacy. Magnetic particle imaging (MPI) has emerged as a suitable modality to quantify in vivo migration of superparamagnetic iron oxide (SPIO)-labeled DC. Herein, we describe a popliteal lymph node (pLN)-focused MPI scan to quantify DC in vivo migration accurately and consistently.MethodsAdenovirus (Ad)-transduced SPIO+ (Ad SPIO+) and SPIO+ C57BL/6 bone marrow-derived DC were generated and assessed for viability and phenotype, then fluorescently labeled and injected into mouse hind footpads (n = 6). Two days later, in vivo DC migration was quantified using whole animal, pLN-focused, and ex vivo pLN MPI scans.ResultsNo significant differences in viability, phenotype and in vivo pLN migration were noted for Ad SPIO+ and SPIO+ DC. Day 2 pLN-focused MPI quantified DC migration in all instances while whole animal MPI only quantified pLN migration in 75% of cases. Ex vivo MPI and fluorescence microscopy confirmed that pLN MPI signal was due to originally injected Ad SPIO+ and SPIO+ DC.ConclusionWe overcame a reported limitation of MPI by using a pLN-focused MPI scan to quantify pLN-migrated Ad SPIO+ and SPIO+ DC in 100% of cases and detected as few as 1000 DC (4.4 ng Fe) in vivo. MPI is a suitable preclinical imaging modality to assess DC-based cancer immunotherapeutic efficacy.Relevance statementTracking the in vivo fate of DC using noninvasive quantifiable magnetic particle imaging can potentially serve as a surrogate marker of therapeutic effectiveness.Key points• Adenoviral-transduced and iron oxide-labeled dendritic cells are in vivo migration competent.• Magnetic particle imaging is a suitable modality to quantify in vivo dendritic cell migration.• Magnetic particle imaging focused field of view overcomes dynamic range limitation.Graphical Abstract
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202309151841914ZK.pdf | 2380KB | download | |
Fig. 7 | 580KB | Image | download |
MediaObjects/12944_2023_1900_MOESM2_ESM.docx | 34KB | Other | download |
Fig. 8 | 95KB | Image | download |
Fig. 2 | 66KB | Image | download |
Fig. 6 | 355KB | Image | download |
Fig. 5 | 129KB | Image | download |
Table 2 | 189KB | Table | download |
42490_2023_74_Article_IEq37.gif | 1KB | Image | download |
Fig. 1 | 87KB | Image | download |
【 图 表 】
Fig. 1
42490_2023_74_Article_IEq37.gif
Fig. 5
Fig. 6
Fig. 2
Fig. 8
Fig. 7
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]
- [57]
- [58]
- [59]
- [60]